




Searching News Database: Dry Eye
HSMN NewsFeed - 26 Mar 2021
European Medicines Agency Accepts Marketing Authorization Application for Enfortumab Vedotin
European Medicines Agency Accepts Marketing Authorization Application for Enfortumab Vedotin
HSMN NewsFeed - 21 Sep 2020
Bausch Health To Acquire Option To Purchase All Ophthalmology Assets Of Allegro Ophthalmics
Bausch Health To Acquire Option To Purchase All Ophthalmology Assets Of Allegro Ophthalmics
HSMN NewsFeed - 7 May 2020
Sight Sciences Introduces the Next-Generation OMNI(R) Surgical System for Microinvasive Glaucoma Surgery
Sight Sciences Introduces the Next-Generation OMNI(R) Surgical System for Microinvasive Glaucoma Surgery
HSMN NewsFeed - 18 Nov 2019
Allergan(R) Announces First Annual National BOTOX(R) Cosmetic (onabotulinumtoxinA) Day
Allergan(R) Announces First Annual National BOTOX(R) Cosmetic (onabotulinumtoxinA) Day
HSMN NewsFeed - 21 Jun 2019
FDA Approves BOTOX(R) (onabotulinumtoxinA) for Pediatric Patients with Upper Limb Spasticity
FDA Approves BOTOX(R) (onabotulinumtoxinA) for Pediatric Patients with Upper Limb Spasticity
HSMN NewsFeed - 29 Jan 2019
Aldeyra Therapeutics Expands Retinal Disease Pipeline with Acquisition of Helio Vision
Aldeyra Therapeutics Expands Retinal Disease Pipeline with Acquisition of Helio Vision
HSMN NewsFeed - 15 May 2018
Surface Pharmaceuticals, Inc. Announces $20 Million Series A Financing from Flying L Partners
Surface Pharmaceuticals, Inc. Announces $20 Million Series A Financing from Flying L Partners
HSMN NewsFeed - 10 May 2018
Aldeyra Therapeutics Appoints David McMullin as Senior Vice President, Corporate Development and Strategy
Aldeyra Therapeutics Appoints David McMullin as Senior Vice President, Corporate Development and Strategy
HSMN NewsFeed - 24 Apr 2018
Aldeyra Therapeutics Announces First Patient Enrolled in Allergic Conjunctivitis Phase 3 Clinical Trial
Aldeyra Therapeutics Announces First Patient Enrolled in Allergic Conjunctivitis Phase 3 Clinical Trial
HSMN NewsFeed - 9 Apr 2018
RegeneRx Announces Outcome of FDA Discussions for Development of RGN-259 for Dry Eye Syndrome
RegeneRx Announces Outcome of FDA Discussions for Development of RGN-259 for Dry Eye Syndrome
HSMN NewsFeed - 8 Jan 2018
I-PEN(R), I-DROP(R) and I-PLUG(R) now available in Spain and Portugal through Partnership with IMEX
I-PEN(R), I-DROP(R) and I-PLUG(R) now available in Spain and Portugal through Partnership with IMEX
HSMN NewsFeed - 19 Oct 2017
Imprimis Pharmaceuticals to Offer Compounded Cyclosporine Alternative to Restasis(R)
Imprimis Pharmaceuticals to Offer Compounded Cyclosporine Alternative to Restasis(R)
HSMN NewsFeed - 31 Aug 2017
RegeneRx Completes License Expansion for RGN-137 in Europe, S. Korea, Japan, Canada and Australia
RegeneRx Completes License Expansion for RGN-137 in Europe, S. Korea, Japan, Canada and Australia
HSMN NewsFeed - 8 May 2017
Lamellar Biomedical Raises £5.75 Million in Series C Fund Raising led by Invesco
Lamellar Biomedical Raises £5.75 Million in Series C Fund Raising led by Invesco
HSMN NewsFeed - 2 May 2017
Imprimis Pharmaceuticals and SightLife Surgical Sign Agreement for National Launch of Serum Tears(TM)
Imprimis Pharmaceuticals and SightLife Surgical Sign Agreement for National Launch of Serum Tears(TM)
HSMN NewsFeed - 19 May 2016
BioLight Expands Its Product Portfolio With Eye Drops for Dry Eye Syndrome
BioLight Expands Its Product Portfolio With Eye Drops for Dry Eye Syndrome
HSMN NewsFeed - 16 May 2016
Allergan Announces Positive Pivotal Trial Results for Oculeve Intranasal Tear Neurostimulator
Allergan Announces Positive Pivotal Trial Results for Oculeve Intranasal Tear Neurostimulator
HSMN NewsFeed - 5 May 2016
TearScience(R) Introduces LipiScan(TM) for Rapid High Definition (HD) Meibomian Imaging
TearScience(R) Introduces LipiScan(TM) for Rapid High Definition (HD) Meibomian Imaging
HSMN NewsFeed - 5 May 2016
TearScience(R) Introduces LipiScan(TM) for Rapid High Definition (HD) Meibomian Imaging
TearScience(R) Introduces LipiScan(TM) for Rapid High Definition (HD) Meibomian Imaging
HSMN NewsFeed - 4 May 2016
Notal Vision Announces Appointment of Quinton Oswald as Chief Executive Officer
Notal Vision Announces Appointment of Quinton Oswald as Chief Executive Officer
HSMN NewsFeed - 29 Jan 2016
RegeneRx Announces Completion of Patient Enrollment In Phase 2b/3 U.S. Dry Eye Trial
RegeneRx Announces Completion of Patient Enrollment In Phase 2b/3 U.S. Dry Eye Trial
HSMN NewsFeed - 22 Jan 2016
U.S. FDA Approves BOTOX(R) (onabotulinumtoxinA) for the Treatment of Lower Limb Spasticity in Adults
U.S. FDA Approves BOTOX(R) (onabotulinumtoxinA) for the Treatment of Lower Limb Spasticity in Adults
HSMN NewsFeed - 25 Aug 2014
NovaBay Pharmaceuticals Deploys Direct Sales Force to Market i-Lid Cleanser Across the U.S.
NovaBay Pharmaceuticals Deploys Direct Sales Force to Market i-Lid Cleanser Across the U.S.
HSMN NewsFeed - 23 Jul 2014
Shire Enters Strategic Licensing and Collaboration Agreement With ArmaGen
Shire Enters Strategic Licensing and Collaboration Agreement With ArmaGen
HSMN NewsFeed - 19 May 2014
Shire Plans to Submit a New Drug Application to FDA for Lifitegrast for Dry Eye Disease in Adults
Shire Plans to Submit a New Drug Application to FDA for Lifitegrast for Dry Eye Disease in Adults
HSMN NewsFeed - 16 Apr 2014
ForSight VISION5 Completes $15MM Series C Funding Round; Company Finishes Enrolling Phase 2 Clinical Study
ForSight VISION5 Completes $15MM Series C Funding Round; Company Finishes Enrolling Phase 2 Clinical Study
HSMN NewsFeed - 6 Jan 2014
Kala Pharmaceuticals Appoints Howard B. Rosen as Chairman of the Board of Directors
Kala Pharmaceuticals Appoints Howard B. Rosen as Chairman of the Board of Directors
HSMN NewsFeed - 30 Dec 2013
OphthaliX Announces Top-Line Results of Phase III Study with CF101 for Dry Eye Syndrome
OphthaliX Announces Top-Line Results of Phase III Study with CF101 for Dry Eye Syndrome
HSMN NewsFeed - 12 Dec 2013
Advanced Cell Technology Appoints Eddy Anglade M.D. Executive Vice President of Clinical Development
Advanced Cell Technology Appoints Eddy Anglade M.D. Executive Vice President of Clinical Development
HSMN NewsFeed - 28 Jun 2013
Eleven Biotherapeutics Appoints Industry Veteran Karen L. Tubridy as Chief Development Officer
Eleven Biotherapeutics Appoints Industry Veteran Karen L. Tubridy as Chief Development Officer
HSMN NewsFeed - 12 Dec 2012
Sucampo Announces FDA Approval of an sNDA for RESCULA(R) (unoprostone isopropyl)
Sucampo Announces FDA Approval of an sNDA for RESCULA(R) (unoprostone isopropyl)
HSMN NewsFeed - 15 Feb 2012
Researchers Show TB4 Provides Both Neuroprotection and Neurorestoration after Traumatic Brain Injury
Researchers Show TB4 Provides Both Neuroprotection and Neurorestoration after Traumatic Brain Injury
HSMN NewsFeed - 1 Feb 2012
TearScience Achieves FDA Clearance for Second Generation LipiFlow(R) Thermal Pulsation System
TearScience Achieves FDA Clearance for Second Generation LipiFlow(R) Thermal Pulsation System
HSMN NewsFeed - 28 Nov 2011
InSite Vision Wins Patent Interference Litigation Against the University of California, San Francisco
InSite Vision Wins Patent Interference Litigation Against the University of California, San Francisco
HSMN NewsFeed - 13 Oct 2011
ISTA Pharmaceuticals Announces Statistically Significant Phase 3 Results for PROLENSA(TM)
ISTA Pharmaceuticals Announces Statistically Significant Phase 3 Results for PROLENSA(TM)
HSMN NewsFeed - 15 Aug 2011
TearScience(R) Appoints Diethart Reichardt as Senior Vice President of European Region
TearScience(R) Appoints Diethart Reichardt as Senior Vice President of European Region
HSMN NewsFeed - 17 Feb 2011
Inspire Announces Corporate Restructuring and Strategic Focus on Eye Care Business
Inspire Announces Corporate Restructuring and Strategic Focus on Eye Care Business
HSMN NewsFeed - 3 Jan 2011
Inspire Announces Results of Second Phase 3 Trial with Denufosol for Cystic Fibrosis
Inspire Announces Results of Second Phase 3 Trial with Denufosol for Cystic Fibrosis
HSMN NewsFeed - 21 Dec 2010
TearScience Wins SEBIO Award for Securing $44.5 Million in Venture Funding in 2010
TearScience Wins SEBIO Award for Securing $44.5 Million in Venture Funding in 2010
HSMN NewsFeed - 12 Oct 2010
Ocular Therapeutix Completes Proof of Principle Study with Moxifloxacin-Loaded Punctum Plugs
Ocular Therapeutix Completes Proof of Principle Study with Moxifloxacin-Loaded Punctum Plugs
HSMN NewsFeed - 1 Sep 2010
Inspire Names Robert Savel as Senior Vice President and Chief Technical Officer
Inspire Names Robert Savel as Senior Vice President and Chief Technical Officer
HSMN NewsFeed - 13 Apr 2010
Inspire Appoints Andrew Koven as Executive Vice President and Chief Administrative and Legal Officer
Inspire Appoints Andrew Koven as Executive Vice President and Chief Administrative and Legal Officer
HSMN NewsFeed - 21 Oct 2009
Auxano Diagnostics, LLC Announces a New Point-of-Care Indicator System for Dry Eye Syndrome
Auxano Diagnostics, LLC Announces a New Point-of-Care Indicator System for Dry Eye Syndrome
HSMN NewsFeed - 5 Oct 2009
Bausch & Lomb Acquires the Commercial Assets of Italian Ophthalmic Pharmaceuticals Company Tubilux
Bausch & Lomb Acquires the Commercial Assets of Italian Ophthalmic Pharmaceuticals Company Tubilux
HSMN NewsFeed - 19 May 2009
TearLab Corporation Announces FDA 510(k) Clearance of the TearLab(tm) Osmolarity System
TearLab Corporation Announces FDA 510(k) Clearance of the TearLab(tm) Osmolarity System
HSMN NewsFeed - 15 Apr 2009
Resolvyx Appoints Industry Leader Philip Vickers as Chief Scientific Officer
Resolvyx Appoints Industry Leader Philip Vickers as Chief Scientific Officer
HSMN NewsFeed - 12 Jan 2009
Abbott Expands Its Growing Medical Device Business With Acquisition of Advanced Medical Optics (AMO)
Abbott Expands Its Growing Medical Device Business With Acquisition of Advanced Medical Optics (AMO)
HSMN NewsFeed - 9 Jan 2009
EyeGate Pharma Receives Orphan Drug Designation for Corneal Graft Rejection From U.S. FDA
EyeGate Pharma Receives Orphan Drug Designation for Corneal Graft Rejection From U.S. FDA
HSMN NewsFeed - 9 Jun 2008
EyeGate Pharma Adds Drug Development and Delivery Expert, Praveen Tyle, to Its Board of Directors
EyeGate Pharma Adds Drug Development and Delivery Expert, Praveen Tyle, to Its Board of Directors
HSMN NewsFeed - 6 Jun 2008
Inspire Announces Achievement of Primary Endpoint in Phase 3 Trial with Denufosol for Cystic Fibrosis
Inspire Announces Achievement of Primary Endpoint in Phase 3 Trial with Denufosol for Cystic Fibrosis
HSMN NewsFeed - 22 Apr 2008
Resolvyx Pharmaceuticals Strengthens Its Board of Directors with Industry Leaders
Resolvyx Pharmaceuticals Strengthens Its Board of Directors with Industry Leaders
HSMN NewsFeed - 1 Apr 2008
Advanced Medical Optics Introduces TECNIS(R) 1-Piece Intraocular Lens in U.S.
Advanced Medical Optics Introduces TECNIS(R) 1-Piece Intraocular Lens in U.S.
HSMN NewsFeed - 30 Jan 2008
Lux Granted Fast Track Designation for LX201 for Corneal Transplant Rejection
Lux Granted Fast Track Designation for LX201 for Corneal Transplant Rejection
HSMN NewsFeed - 25 Oct 2007
Sirion Therapeutics Announces Positive Phase III Results for Difluprednate
Sirion Therapeutics Announces Positive Phase III Results for Difluprednate
HSMN NewsFeed - 7 Sep 2007
Bausch & Lomb Launches the Stellaris(TM) Vision Enhancement System in Europe at ESCRS 2007
Bausch & Lomb Launches the Stellaris(TM) Vision Enhancement System in Europe at ESCRS 2007
HSMN NewsFeed - 23 Aug 2007
Antares Announces Initiation of Pivotal Trial of ANTUROL(TM) for the Treatment of Overactive Bladder
Antares Announces Initiation of Pivotal Trial of ANTUROL(TM) for the Treatment of Overactive Bladder
HSMN NewsFeed - 13 Aug 2007
Inspire Pharmaceuticals Launches AzaSite(TM) in the United States for Ocular Infections
Inspire Pharmaceuticals Launches AzaSite(TM) in the United States for Ocular Infections
HSMN NewsFeed - 7 Aug 2007
Lux Granted Fast Track Designation by FDA for LX211 for the Treatment of Uveitis
Lux Granted Fast Track Designation by FDA for LX211 for the Treatment of Uveitis
HSMN NewsFeed - 25 Jul 2007
Antares Reaches Agreement with FDA on Special Protocol Assessment for Pivotal Trial of Anturol(TM)
Antares Reaches Agreement with FDA on Special Protocol Assessment for Pivotal Trial of Anturol(TM)
HSMN NewsFeed - 5 Jul 2007
Advanced Medical Optics Confirms $75 Per Share Proposal to Acquire Bausch & Lomb
Advanced Medical Optics Confirms $75 Per Share Proposal to Acquire Bausch & Lomb
HSMN NewsFeed - 7 Jun 2007
Inspire Adds Stephen D. Celestini as Senior Vice President and Chief Compliance Officer
Inspire Adds Stephen D. Celestini as Senior Vice President and Chief Compliance Officer
HSMN NewsFeed - 16 Apr 2007
Sirion Therapeutics Receives Orphan Drug Designation for Ophthalmic Drug to Treat Viral Eye Infection
Sirion Therapeutics Receives Orphan Drug Designation for Ophthalmic Drug to Treat Viral Eye Infection
HSMN NewsFeed - 15 Jan 2007
Lux Biosciences Receives Orphan Drug Designation from the FDA for Two Ophthalmic Products
Lux Biosciences Receives Orphan Drug Designation from the FDA for Two Ophthalmic Products
HSMN NewsFeed - 11 Nov 2006
Bausch & Lomb Showcases New Technologies at American Academy of Ophthalmology Annual Meeting
Bausch & Lomb Showcases New Technologies at American Academy of Ophthalmology Annual Meeting
HSMN NewsFeed - 20 Oct 2006
FDA Approves New, Once-a-Day COREG CR(TM) for the Treatment of Three Key Cardiovascular Conditions
FDA Approves New, Once-a-Day COREG CR(TM) for the Treatment of Three Key Cardiovascular Conditions
HSMN NewsFeed - 21 Sep 2006
Alcon's TRAVATAN(R) Z Solution Approved by FDA for Treatment of Glaucoma and Ocular Hypertensive Patients
Alcon's TRAVATAN(R) Z Solution Approved by FDA for Treatment of Glaucoma and Ocular Hypertensive Patients
HSMN NewsFeed - 27 Jul 2006
Inspire Initiates Phase 3 Clinical Trial of Denufosol Tetrasodium in Cystic Fibrosis Patients
Inspire Initiates Phase 3 Clinical Trial of Denufosol Tetrasodium in Cystic Fibrosis Patients
HSMN NewsFeed - 19 Jul 2006
Somaxon Pharmaceuticals Provides Update on SILENOR(TM) Development Program for the Treatment of Insomnia
Somaxon Pharmaceuticals Provides Update on SILENOR(TM) Development Program for the Treatment of Insomnia
HSMN NewsFeed - 17 May 2006
New Data Show COREG CR (TM) Reduced Blood Pressure in Patients With Essential Hypertension
New Data Show COREG CR (TM) Reduced Blood Pressure in Patients With Essential Hypertension
HSMN NewsFeed - 3 May 2006
Othera Pharmaceuticals Elects Katherine Crothall and Bruce Peacock to Board
Othera Pharmaceuticals Elects Katherine Crothall and Bruce Peacock to Board
HSMN NewsFeed - 22 Mar 2006
Othera Pharmaceuticals Appoints Al Reaves as Senior Vice President of Clinical Development
Othera Pharmaceuticals Appoints Al Reaves as Senior Vice President of Clinical Development
HSMN NewsFeed - 14 Mar 2006
New Drug Application for COREG CR(TM) Accepted for Review by U.S. Food and Drug Administration
New Drug Application for COREG CR(TM) Accepted for Review by U.S. Food and Drug Administration
Additional items found! 41

Members Archive contains
41 additional stories matching:
Dry Eye
(Password required)
Dry Eye
(Password required)